SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cytrx Corp. – ‘8-K’ for 5/19/22 – ‘EX-3.3’

On:  Thursday, 5/19/22, at 5:30pm ET   ·   For:  5/19/22   ·   Accession #:  1493152-22-14514   ·   File #:  0-15327

Previous ‘8-K’:  ‘8-K’ on / for 3/21/22   ·   Next:  ‘8-K’ on 6/2/22 for 5/27/22   ·   Latest:  ‘8-K/A’ on 10/12/23 for 9/6/23   ·   5 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/19/22  Cytrx Corp.                       8-K:3,5,7,9 5/19/22   13:270K                                   M2 Compliance LLC/FA

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     46K 
 2: EX-3.2      Articles of Incorporation/Organization or Bylaws    HTML      9K 
 3: EX-3.3      Articles of Incorporation/Organization or Bylaws    HTML     11K 
 4: EX-99.1     Miscellaneous Exhibit                               HTML     13K 
 8: R1          Cover                                               HTML     50K 
11: XML         IDEA XML File -- Filing Summary                      XML     12K 
 9: XML         XBRL Instance -- form8-k_htm                         XML     16K 
10: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 6: EX-101.LAB  XBRL Labels -- cytr-20220519_lab                     XML    101K 
 7: EX-101.PRE  XBRL Presentations -- cytr-20220519_pre              XML     65K 
 5: EX-101.SCH  XBRL Schema -- cytr-20220519                         XSD     14K 
12: JSON        XBRL Instance as JSON Data -- MetaLinks               25±    33K 
13: ZIP         XBRL Zipped Folder -- 0001493152-22-014514-xbrl      Zip     21K 


‘EX-3.3’   —   Articles of Incorporation/Organization or Bylaws


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 

EXHIBIT 3.3

 

STATE OF DELAWARE
CERTIFICATE OF CORRECTION

 

CytRx Corporation, a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, does hereby certify as follows:

 

1.The name of the corporation is CytRx Corporation.
   
2.That a Certificate of Amendment to Restated Certificate of Incorporation of CytRx Corporation (the “Certificate”) was filed with the Secretary of State of Delaware on March 16, 2022 and that said Certificate requires correction as permitted by Section 103 of the General Corporation Law of the State of Delaware.
   
3.The inaccuracy or defect of said Certificate is: The first paragraph of Article FOURTH incorrectly states that the par value per share of CytRx Corporation preferred stock is $0.1 per share, when it should state that such par value is $0.01 per share.
   
4.The Article FOURTH of the Certificate is corrected to read as follows:

 

FOURTH. The total number of shares of all classes of stock that the corporation shall have the authority to issue is Sixty-Three Million Two Hundred Twenty-Seven Thousand Two-Hundred Seventy-Three (63,227,273), of which Sixty-Two Million Three Hundred Ninety-Three Thousand Nine Hundred Forty (62,393,940) shall be common stock, par value $0.001 per share (the “Common Stock”), and Eight Hundred Thirty-Three Thousand Three Hundred Thirty-Three (833,333) shall be preferred stock, par value $0.01 per share (the “Preferred Stock”).

 

The Board of Directors is hereby authorized, subject to any limitations prescribed by law, to provide for the issuance of the shares of Preferred Stock in series, and by filing a Certificate pursuant to the applicable law of the State of Delaware (hereinafter referred to as a “Preferred Stock Designation”), to establish from time to time the number of shares to be included in each such series, and to fix the designations, powers, preferences, and rights of the shares of each such series, any qualifications, limitations or restrictions thereof.”

 

IN WITNESS WHEREOF, said corporation has caused this Certificate of Correction this 19th day of May, 2022.

 

  By: /s/ John Y. Caloz
  Name: John Y. Caloz
  Title: Chief Financial Officer

 

 C: 
 

 

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
Filed on / For Period end:5/19/228-A12G
3/16/228-K
 List all Filings 


4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/27/24  LadRx Corp.                       10-K       12/31/23   67:19M                                    M2 Compliance LLC/FA
 4/14/23  LadRx Corp.                       S-1                   66:6M                                     M2 Compliance LLC/FA
 3/20/23  LadRx Corp.                       10-K       12/31/22   72:6.2M                                   M2 Compliance LLC/FA
 8/11/22  LadRx Corp.                       10-Q        6/30/22   47:3.5M                                   M2 Compliance LLC/FA


1 Previous Filing that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/19/22  LadRx Corp.                       8-A12G                 2:82K                                    M2 Compliance LLC/FA
Top
Filing Submission 0001493152-22-014514   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 7:07:54.1am ET